• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Louisiana HB 527 pushed back by sponsor

Article

HB 527, which would allow expanded privileges to optometrists, was not brought to the Louisiana House floor last week as planned.

Baton Rouge, LA-Rep. Frank Hoffman (R-LA) declined to allow HB 527 to come to the House floor last week, and the bill is now on hold. The bill allows optometrists to: determine the scope of the practice of optometry, administer medication by injection, and perform several laser procedures (Yag, peripheral iridotomy [PI], and selective laser trabeculoplasty (SLT).

Says James Sandefur, OD, executive director of the Optometry Association of Louisiana: “The author decided to put the bill back on the calendar and not move forward with it. It’s probably dead for the session. We can’t force the author to bring the bill to a vote. If nothing happens this session, our legislative committee and board of directors will have to decide if we want to do something next year.”

Related Videos
Shan Lin, MD, speaks on Glaucoma 360 presentation in an interview with Ophthalmology Times
Cecelia Koetting, OD, FAAO, DIPABO, left, speaks with Optometry Times about the 2024 EnVision Summit
Bonnie An Henderson, MD, highlights key takeaways of the 2024 EnVision Summit, including diversity and family inclusion
Danica Marrelli, OD, FAAO, AAO Dipl, co-chair of EnVision Summit chats about geographic atrophy and glaucoma panels
Robert Weiss, former CEO and President of The Cooper Companies, Inc. (left) and Optometry Times' Assistant Managing Editor Emily Kaiser Maharjan Image Credit ©Optometry Times
© 2024 MJH Life Sciences

All rights reserved.